Pharmaceuticals by one-year price change
How far the share price has moved over the last 52 weeks.
Alnylam Pharmaceuticals has the lowest figure of the 61 pharmaceuticals ranked by one-year price change, at -66.0%, followed by Ionis Pharmaceuticals (-63.6%) and Legend Biotech (-42.5%). Figures as of 18 Nov 2026, 16:40 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Alnylam Pharmaceuticals-66.0%
- Median
- +26.9%
- Combined market value
- SAR 19.07T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | SAR 76.3B | SAR 569.91 | 2.92% down | 66% down | ||
| 2 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | SAR 17B | SAR 102.35 | 1.21% up | 64% down | ||
| 3 | Legend BiotechLEGN · Health Care | -42.5% | SAR 11.8B | SAR 60.62 | 0.31% up | 42% down | ||
| 4 | InsmedINSM · Health Care | -40.1% | SAR 98.7B | SAR 449.86 | 1.58% down | 40% down | ||
| 5 | Summit TherapeuticsSMMT · Health Care | -35.6% | SAR 31.8B | SAR 39.82 | 0.52% down | 36% down | ||
| 6 | ZoetisZTS · Health Care | -28.7% | SAR 127.9B | SAR 314.69 | 0.50% up | 29% down | ||
| 7 | ABIVAXABVX · Health Care | -27.3% | SAR 27.5B | SAR 314.11 | 2.00% up | 27% down | ||
| 8 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | SAR 35.4B | SAR 1,522.53 | 3.81% down | 24% down | ||
| 9 | Cogent BiosciencesCOGT · Health Care | -20.3% | SAR 18.4B | SAR 105.98 | 1.45% up | 20% down | ||
| 10 | CytokineticsCYTK · Health Care | -20.3% | SAR 26.8B | SAR 192.05 | 0.87% down | 20% down | ||
| 11 | PTC TherapeuticsPTCT · Health Care | -20.2% | SAR 18.9B | SAR 225.89 | 0.23% down | 20% down | ||
| 12 | Abbott LaboratoriesABT · Health Care | -17.0% | SAR 679.7B | SAR 392.47 | 0.08% down | 17% down | ||
| 13 | Novo NordiskNVO · Health Care | -16.9% | SAR 653.5B | SAR 148.28 | 2.87% down | 17% down | ||
| 14 | Corcept TherapeuticsCORT · Health Care | -7.92% | SAR 27.9B | SAR 254.54 | 3.15% down | 8% down | ||
| 15 | Axsome TherapeuticsAXSM · Health Care | -7.37% | SAR 26.3B | SAR 500.91 | 1.77% down | 7% down | ||
| 16 | SanofiSNY · Health Care | -4.08% | SAR 426B | SAR 177.40 | 0.49% down | 4% down | ||
| 17 | GrifolsGRFS · Health Care | +1.41% | SAR 21.7B | SAR 31.90 | 1.45% down | 1% up | ||
| 18 | AstraZenecaAZN · Health Care | +2.41% | SAR 1.04T | SAR 671.77 | 1.74% down | 2% up | ||
| 19 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | SAR 46.9B | SAR 56.21 | 1.32% up | 5% up | ||
| 20 | GSKGSK · Health Care | +6.26% | SAR 367.1B | SAR 183.12 | 0.85% down | 6% up | ||
| 21 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | SAR 22.8B | SAR 161.37 | 0.07% up | 10% up | ||
| 22 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | SAR 43.7B | SAR 225.47 | 2.73% up | 11% up | ||
| 23 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | SAR 30.4B | SAR 438.68 | 0.29% up | 13% up | ||
| 24 | PfizerPFE · Health Care | +14.4% | SAR 601.7B | SAR 105.57 | 1.14% down | 14% up | ||
| 25 | BeOne MedicinesONC · Health Care | +16.8% | SAR 172.9B | SAR 1,513.94 | 2.34% down | 17% up | ||
| 26 | BridgeBio PharmaBBIO · Health Care | +17.2% | SAR 56.7B | SAR 291.12 | 1.05% up | 17% up | ||
| 27 | Elanco Animal HealthELAN · Health Care | +20.5% | SAR 49.6B | SAR 99.14 | 2.24% up | 20% up | ||
| 28 | United TherapeuticsUTHR · Health Care | +22.6% | SAR 92.5B | SAR 2,172.04 | 0.86% down | 23% up | ||
| 29 | NovartisNVS · Health Care | +25.0% | SAR 1.1T | SAR 584.59 | 2.06% down | 25% up | ||
| 30 | AbbVieABBV · Health Care | +25.7% | SAR 1.92T | SAR 1,084.15 | 1.29% down | 26% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | SAR 508.2B | SAR 2,004.59 | 0.04% up | 27% up | ||
| 32 | Ascendis PharmaASND · Health Care | +27.8% | SAR 66.5B | SAR 1,013.90 | 0.33% down | 28% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | SAR 22.4B | SAR 342.75 | 0.63% down | 31% up | ||
| 34 | Belite BioBLTE · Health Care | +31.0% | SAR 24.1B | SAR 593.37 | 0.30% up | 31% up | ||
| 35 | Bristol-Myers SquibbBMY · Health Care | +34.0% | SAR 461.4B | SAR 225.72 | 1.92% down | 34% up | ||
| 36 | Eli LillyLLY · Health Care | +34.9% | SAR 4.64T | SAR 5,205.71 | 1.96% down | 35% up | ||
| 37 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | SAR 371.3B | SAR 3,589.07 | 0.10% down | 36% up | ||
| 38 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | SAR 58.7B | SAR 915.08 | 1.35% up | 37% up | ||
| 39 | Johnson & JohnsonJNJ · Health Care | +37.6% | SAR 2.49T | SAR 1,033.64 | 1.12% down | 38% up | ||
| 40 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | SAR 22.5B | SAR 1,126.16 | 2.19% up | 43% up | ||
| 41 | Travere TherapeuticsTVTX · Health Care | +44.2% | SAR 18.1B | SAR 188.38 | 1.72% down | 44% up | ||
| 42 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | SAR 30.7B | SAR 470.19 | 0.55% up | 46% up | ||
| 43 | Merck & CoMRK · Health Care | +50.8% | SAR 1.29T | SAR 523.75 | 2.61% down | 51% up | ||
| 44 | Takeda PharmaceuticalTAK · Health Care | +53.6% | SAR 256B | SAR 80.12 | 1.30% down | 54% up | ||
| 45 | AlkermesALKS · Health Care | +58.4% | SAR 29.4B | SAR 175.02 | 2.66% up | 58% up | ||
| 46 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | SAR 32.1B | SAR 1,147.84 | 0.31% up | 61% up | ||
| 47 | GenmabGMAB · Health Care | +70.0% | SAR 118.3B | SAR 191.92 | 1.53% down | 70% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | SAR 184.8B | SAR 158.35 | 0.95% down | 74% up | ||
| 49 | Royalty PharmaRPRX · Health Care | +77.7% | SAR 148.2B | SAR 257.81 | 0.07% up | 78% up | ||
| 50 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | SAR 28.1B | SAR 80.68 | 1.85% up | 83% up | ||
| 51 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | SAR 16.9B | SAR 154.28 | 2.16% down | 88% up | ||
| 52 | Roivant SciencesROIV · Health Care | +90.3% | SAR 104.6B | SAR 144.36 | 0.58% down | 90% up | ||
| 53 | ViatrisVTRS · Health Care | +95.5% | SAR 88.5B | SAR 77.23 | 0.68% up | 96% up | ||
| 54 | TG TherapeuticsTGTX · Health Care | +107% | SAR 36.9B | SAR 244.38 | 3.89% up | 107% up | ||
| 55 | Dianthus TherapeuticsDNTH · Health Care | +113% | SAR 18.2B | SAR 322.74 | 1.08% down | 113% up | ||
| 56 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | SAR 28.3B | SAR 360.17 | 0.96% up | 126% up | ||
| 57 | Definium TherapeuticsDFTX · Health Care | +169% | SAR 14.7B | SAR 107.13 | 2.79% down | 169% up | ||
| 58 | VeradermicsMANE · Health Care | +233% | SAR 19.8B | SAR 469.25 | 0.43% down | 233% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | +241% | SAR 24.5B | SAR 361.41 | 0.03% up | 241% up | ||
| 60 | Spyre TherapeuticsSYRE · Health Care | +286% | SAR 33.9B | SAR 356.76 | 1.39% up | 286% up | ||
| 61 | ErascaERAS · Health Care | +403% | SAR 17.3B | SAR 49.19 | 5.58% down | 403% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which pharmaceuticals have the lowest one-year price change?
Alnylam Pharmaceuticals (-66.0%), Ionis Pharmaceuticals (-63.6%) and Legend Biotech (-42.5%) have the lowest one-year price change of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 16:40 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by one-year price change have a combined market value of SAR 19.07T as of 18 Nov 2026, 16:40 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceuticals by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.